Benign Prostatic Hyperplasia
📧 Sign up to get email alerts when something new happens for Benign Prostatic Hyperplasia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-07-11FDA Approved: TAMSULOSIN HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for tamsulosin hydrochloride from Aurobindo Pharma Limited.
-
FDA approval · 2015-07-06FDA Approved: PROSCAR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for PROSCAR (finasteride) submitted by Organon LLC.
-
CLINICAL_TRIALS trial_result · 2015-06-29Clinical Trial Update: Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia [Phase 2]
Phase 2 trial evaluating the safety and efficacy of WC3055 in men with lower urinary tract symptoms due to benign prostatic hyperplasia has …
-
FDA label_change · 2015-06-08FDA Approved: CARDURA XL — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for CARDURA XL (doxazosin mesylate) by Viatris Specialty LLC, typically resulting in labeling change…
-
CLINICAL_TRIALS research · 2015-06-03Clinical Trial Update: The Role of microRNAs in Organ Remodeling in Lower Urinary Tract Dysfunction
A completed ClinicalTrials.gov study update investigating the role of microRNAs in organ remodeling during lower urinary tract dysfunction, …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2015-06-03Clinical Trial Update: BOTOX in Men With Prostate Cancer With Lower Urinary Tract Symptoms(LUTS)/Benign Prostatic Hyperplasia (BPH) [EARLY_Phase 1]
This clinical trial evaluating onabotulinumtoxinA (BOTOX) for men with prostate cancer and lower urinary tract symptoms/benign prostatic hyp…
-
FDA approval · 2015-06-01FDA Approved: ALFUZOSIN HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for Alfuzosin Hydrochloride from Sun Pharmaceutical Industries, Inc., updating the product's reg…
-
CLINICAL_TRIALS trial_result · 2015-05-14Clinical Trial Update: A Trial of Degarelix in Men With Lower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperplasia (BPH) [Phase 2]
Phase 2 trial of degarelix for lower urinary tract symptoms due to benign prostatic hyperplasia has been completed, with results posted on 2…
-
CLINICAL_TRIALS research · 2015-05-14Clinical Trial Update: Comparison of Medical and Surgical Treatments of Benign Prostate Hyperplasia in Patients Who Have Low Grade Non Muscle Invasive Bladder Cancer for Tumour Recurrence and Progression [Phase 4]
Phase 4 clinical trial comparing medical versus surgical treatment options for benign prostatic hyperplasia in patients with low-grade non-m…
-
CLINICAL_TRIALS trial_result · 2015-05-12Clinical Trial Update: Evaluation of the Effects of Different Prostate Surgeries on Urinary and Sexual Function [Phase 4]
A Phase 4 clinical trial evaluating how different prostate surgical procedures affect urinary and sexual function in adult men; the study ha…
-
CLINICAL_TRIALS trial_result · 2015-05-01Clinical Trial Update: Dutasteride With Tolterodine ER or Placebo to Treat Lower Urinary Tract Symptoms (LUTS) [Phase 4]
Phase 4 trial assessed dutasteride with tolterodine ER versus placebo for lower urinary tract symptoms in men with benign prostatic hyperpla…
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Saline With Alcohol in TransUrethral Resection aNd Photoselective Vaporisation of the Prostate [NA]
Clinical trial update indicates a study evaluating saline with alcohol in transurethral resection and photoselective vaporisation of the pro…
-
FDA approval · 2015-04-22FDA Approved: TAMSULOSIN HYDROCHLORIDE — Supplemental Application (Zydus Lifesciences Limited)
The FDA approved a supplemental application for tamsulosin hydrochloride submitted by Zydus Lifesciences Limited.
-
CLINICAL_TRIALS trial_result · 2015-04-07Clinical Trial Update: 2013 Annual National Digital Rectal Exam (DRE) Day Study
This document reports the completion of the 2013 Annual Digital Rectal Exam Day study sponsored by St. Luke's Medical Center (Philippines), …
-
CLINICAL_TRIALS research · 2015-04-07Clinical Trial Update: Configuration of a New Prostate Disease Nomogram Predicting Prostate Biopsy Outcome
This completed clinical trial describes a new nomogram configuration designed to predict the outcome of prostate biopsies in patients with p…
-
FDA approval · 2015-04-06FDA Approved: FINASTERIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental application for Finasteride (generic) under ANDA090061.
-
FDA approval · 2015-03-20FDA Approved: TERAZOSIN — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)
FDA approved a supplemental application for terazosin hydrochloride from Jubilant Cadista Pharmaceuticals Inc., related to the generic teraz…
-
FDA approval · 2015-03-19FDA Approved: FINASTERIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental application for Finasteride (generic), confirming approval of changes to the product. Fina…
-
CLINICAL_TRIALS trial_result · 2015-03-03Clinical Trial Update: MCS in the Treatment of Lower Urinary Tract Symptoms [Phase 2, Phase 3]
Clinical trial update on MCS for lower urinary tract symptoms including benign prostatic hyperplasia, conducted in Phase 2 and Phase 3, with…
-
CLINICAL_TRIALS trial_result · 2015-03-03Clinical Trial Update: Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms (MCS-2-US-c) [Phase 3]
This document reports the completion of an open-label extension study (Phase 3) evaluating MCS-2 for lower urinary tract symptoms and benign…
-
CLINICAL_TRIALS trial_result · 2015-02-25Clinical Trial Update: QUAPELLA (QUAlity of Prostate Enucleation by LUMENIS - Laser)
Completed clinical trial update for QUAPELLA, a laser-based prostate enucleation approach evaluated in benign prostatic hyperplasia.
-
FDA approval · 2015-02-24FDA Approved: DOXAZOSIN — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for doxazosin mesylate from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Safety and Pharmacokinetic Interaction Study of Tadalafil and Dutasteride [Phase 1]
Phase 1 safety and pharmacokinetic interaction study of tadalafil and dutasteride in benign prostatic hyperplasia completed.
-
FDA approval · 2015-01-15FDA Approved: ALFUZOSIN HYDROCHLORIDE — Supplemental Application (Apotex Corp.)
FDA approved Apotex Corp.'s supplemental application for alfuzosin hydrochloride, a generic product under the ANDA program.
-
FDA approval · 2015-01-14FDA Approved: ALFUZOSIN HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Alfuzosin hydrochloride from Aurobindo Pharma Limited, indicating regulatory approval for this g…